Healthcare providers worldwide are placing greater emphasis on supportive treatments that improve the overall cancer care experience, contributing to the expansion of the global Chemotherapy Induced Peripheral Neuropathy market. The pursuit of safer and more effective symptom management solutions is fostering innovation across pharmaceuticals, rehabilitation therapies, and patient-centered...